Many women report not feeling completely informed about breast cancer treatment options

December 15, 2017, American College of Surgeons

Breast cancer is the second most common cancer among women in the United States, with more than 230,000 women diagnosed annually. (Skin cancer remains the most common.) Patients often describe the process of making a treatment decision as worrisome, so one research team wanted to explore how these patients became informed about their treatment options, and why some women might feel less than completely informed.

The researchers found that the majority of women who had operations reported not feeling completely informed about their options. In a separate study, another research team found a possible solution: using a web-based aid tool, which improved patients' knowledge of treatment options more than standard websites. Patients using the decision aid were more likely to recognize that waiting a few weeks to make a decision regarding their cancer operations would not negatively impact survival. Results from both studies appear on the Journal of the American College of Surgeons website as "articles in press" ahead of print publication.

"We were really interested in providing the patient perspective," said Sunny Mitchell, MD, a breast surgeon in Stratford, CT, and the lead author of the first study, based on a nationwide survey that found the majority of women did not feel completely informed about their treatment options before undergoing . "On top of exploring how women become informed about their treatment options, we also wanted to identify any opportunities for improvement," Dr. Mitchell said.

The study, designed as a post-treatment survey, was administered by an independent public opinion research firm and completed via the Internet in June 2016. Participants were recruited from health advocacy groups, clinics, and other health-related organizations, and were eligible to take the survey if they were female, ages 18-99, received a breast cancer diagnosis, and had undergone lumpectomy, mastectomy, or both procedures. There were 487 respondents who completed the survey.

When asked if researching all their options or making a quick decision was a priority, 35 percent of the lumpectomy-only patients, 31 percent of the mastectomy-only patients, and 22 percent of the group of patients who had both operations, said that making a quick decision was more important. When asked how strongly patients agreed or disagreed that they wished they had more time to explore different breast cancer surgery options, the majority of all three groups agreed somewhat or strongly that they wished they had more time.

The survey also asked participants how informed or uninformed they felt about treatment options before undergoing breast cancer operations. The authors found that, among lumpectomy patients, only 47 percent said they felt completely informed. Among mastectomy patients, 67 percent said they felt completely informed. Among patients who had both operations, only 28 percent said they felt completely informed.

Dr. Mitchell said she was "definitely surprised by the large percentage of women who reported not feeling completely informed." In order to address this deficiency, Dr. Mitchell said that future studies could focus on providing consistent, reliable information in a variety of formats, and measuring which ones are the most effective. Formats could include brochures, decision aids, and videos to ensure that patients have enough information to make advance treatment decisions.

While many patients will make efforts to educate themselves on their own, the authors wrote, "it is unrealistic to expect that the majority of patients have sufficient health literacy, research skills, information access, and clarity of mind to inform themselves" about all treatment options, and to make the best decision. Therefore, it should be the responsibility of the physician to educate the patient about treatment options and to ensure she's sufficiently informed to make a decision. In addition to providing the information, Dr. Mitchell noted that physicians should also reassure patients. Although timely treatment should be initiated, she said, patients do actually have more time than they think to make a .

Like Dr. Mitchell's team, the second research team was also interested in how patients received information about . These researchers studied decision aids and found that these materials were more effective in informing patients when compared with standard cancer information websites. During their initial surgical consultations, who used the web-based decision aid tools were more engaged, better able to articulate their concerns, and quicker to voice their opinions, said lead study author Heather Neuman, MD, MS, FACS, an associate professor in the department of surgery at the University of Wisconsin-Madison.

From April 2014 to June 2016, the research team randomized women newly diagnosed with stages 0 to III breast cancer who were considering an operation within the UW breast program by sending them a web link via email. The link took patients to either a web-based decision aid or to standard cancer websites, including, the American Cancer Society, and the National Cancer Institute. The decision aid utilizes static, didactic information written for an eighth grade reading level and video clinical vignettes.

"In addition to providing information, the decision aid allows patients to compare choices by presenting the information in a parallel way," Dr. Neuman said. "It includes extra pieces of information that prompt patients to think about their values and preferences."

After receiving the links and reviewing the information, patients received a questionnaire in the clinic prior to their first surgical consultation. Researchers measured patient knowledge, the primary outcome, using a breast cancer decision quality instrument. The instrument presented five items to assess knowledge on key concepts relevant to decision making for a breast cancer operation.

The authors found that patients who received links to the decision aid demonstrated higher overall knowledge (median score of 80 percent on the questionnaire) compared with patients who received links to the standard websites (median score of 66 percent). Additionally, 72 percent of patients who received the decision aid recognized that waiting a few weeks to make a decision about their breast cancer operations would not negatively impact survival, compared with 54 percent of patients who received links to standard websites.

"Patients come in with this urgency, and this finding tells them they can slow down. They don't need to have that anxiety," Dr. Neuman said, adding that her team plans to conduct a similar study on the use of decision aids in an underserved community in Memphis, Tenn.

Decreasing the urgency surrounding the decision-making process may in turn increase the quality of the surgeon-patient consultation, the authors wrote, as patients may be more open to hearing the options and better prepared to consider them. Dr. Neuman emphasized that

receiving information in any form from a physician—rather than having to search for things online themselves—is very helpful.

"This process of sending something by email works, and for a general surgeon in a more rural area, that's something they could do to improve care," she said.

Explore further: How decision-making habits influence the breast cancer treatments women consider

More information: How Well Informed Do Patients Feel About Their Breast Cancer Surgery Options: Findings from a Nationwide Survey of Women after Lumpectomy and/or Mastectomy. Journal of the American College of Surgeons.

A randomized controlled trial evaluating the impact of web-based information on breast cancer patients' knowledge of surgical treatment options. Journal of the American College of Surgeons.

Related Stories

How decision-making habits influence the breast cancer treatments women consider

August 15, 2017
A new study finds that more than half of women with early stage breast cancer considered an aggressive type of surgery to remove both breasts. The way women generally approach big decisions, combined with their values, impacts ...

When the doctor recommends against the surgery a breast cancer patient wants

April 5, 2017
More women with breast cancer are electing to have both breasts removed, even when cancer affects only one breast. The procedure, called contralateral prophylactic mastectomy (CPM), is a more complex surgery that has not ...

Most breast cancer patients have help choosing treatments

July 10, 2017
(HealthDay)—Most women who've been diagnosed with breast cancer don't go it alone.

How family and friends influence breast cancer treatment decisions

June 28, 2017
When a woman walks into the oncologist's office, she's usually not alone. In fact, a new study finds that half of women have at least three people standing behind them, sitting next to them or waiting at home to help.

Study finds gaps in patient knowledge of breast reconstruction surgery and complications

January 8, 2016
A study by University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators has uncovered a need to better inform breast cancer patients about the pros and cons of breast reconstructive surgery ...

Recommended for you

In zebrafish, a way to find new cancer therapies, targeting tumor modulators

September 21, 2018
The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes. Looking for a way to test for their presence in zebrafish, their go-to research ...

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.